iRhythm Technologies, Inc. (IRTC)

Market Cap	3.47B
Revenue (ttm)	492.68M
Net Income (ttm)	-123.41M
Shares Out	30.98M
EPS (ttm)	-4.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	264,422
Open	111.55
Previous Close	112.12
Day's Range	110.39 - 114.63
52-Week Range	70.24 - 140.23
Beta	1.31
Analysts	Strong Buy
Price Target	131.40 (+17.23%)
Earnings Date	May 2, 2024

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 2,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC

Financial Performance

In 2023, IRTC's revenue was $492.68 million, an increase of 19.90% compared to the previous year's $410.92 million. Losses were -$123.41 million, 6.24% more than in 2022.

Analyst Forecast

According to 10 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price forecast is $131.4, which is an increase of 17.23% from the latest price.

Price Target

$131.4

(17.23% upside)

Analyst Consensus: Strong Buy